GlaxoSmithKline Pharmaceuticals has informed that in terms of the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading period for buying or selling of Company’s shares is closed from July 01, 2016 and shall reopen on August 01, 2016 i.e. after the approval and declaration of Un-Audited Financial Results for the first quarter ended June 30, 2016, by the Board of Directors at its meeting scheduled to be held on July 28, 2016.
The above information is a part of company’s filings submitted to BSE.
